Venous Thromboembolism (VTE) Treatment Market is projected to witness significant growth, reaching USD 2.13 billion by 2032, with a compound annual growth rate (CAGR) of 8.50% from 2024 to 2032. The market was valued at USD 1.05 billion in 2023, driven by the rising incidence of venous thromboembolism, technological advancements in treatment options, and the growing demand for effective and...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian